With increasing concerns about oral phenylephrine ineffectiveness, a team including CP3's Drs. Tim Anderson, Katie Suda, and Walid Gellad, examined oral decongestant purchasing patterns, highlighting differences in timing of concerns versus action from the FDA. "The FDA needs to hold over-the-counter drugs to a standard of effectiveness similar to that of prescription drugs," CP3 Faculty Affiliate Dr. Tim Anderson said of the team's findings.